Exclusive

Publication

Byline

Singapore Clinical Trial: A Master Protocol of an Open-Label, Multi-Drug, Multi-Centre, Phase II Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Immunogenicity, and Antitumour Activity of Novel Combinations in Participants with Locally Advanced or Metastatic Non-Small Cell Lung Cancer (LIBRA)

Singapore, April 21 -- The Health Sciences Authority received information related to the study titled 'A Master Protocol of an Open-Label, Multi-Drug, Multi-Centre, Phase II Study to Evaluate the Safe... Read More


Singapore Clinical Trial: Role of glucagon-like peptide 1 receptor Agonist (GLP1 RA) Dulaglutide on cerebral hemodynamics In patients with severe and symptomAtic steNosis of inTracranial internal carotid artery or middle cerebral artery with impaired cerebral vasodilatory reserve- an open-label randomised clinical trial (RADIANT)

Singapore, April 21 -- The Health Sciences Authority received information related to the study titled 'Role of glucagon-like peptide 1 receptor Agonist (GLP1 RA) Dulaglutide on cerebral hemodynamics I... Read More


Singapore Clinical Trial: A randomized, placebo-controlled, participant- and investigator-blinded study to evaluate the efficacy in reducing atrial fibrillation burden (AFB) as well as the safety, tolerability, and pharmacokinetics of oral PKN605 in participants with atrial fibrillation

Singapore, April 21 -- The Health Sciences Authority received information related to the study titled 'A randomized, placebo-controlled, participant- and investigator-blinded study to evaluate the eff... Read More


Singapore Clinical Trial: A Phase 2/3 Randomized Study to Evaluate the Safety, Efficacy, and Optimal Dose of Telisotuzumab Adizutecan in Combination with Osimertinib as First-Line Treatment in Patients with Locally Advanced Unresectable or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung Cancer

Singapore, April 21 -- The Health Sciences Authority received information related to the study titled 'A Phase 2/3 Randomized Study to Evaluate the Safety, Efficacy, and Optimal Dose of Telisotuzumab ... Read More


Singapore Clinical Trial: A Study to Evaluate the Effect of Fasting Duration and Temporary Withholding of Tirzepatide on Retained Gastric Contents Using Gastric Ultrasound in Participants with Type 2 Diabetes Mellitus and Participants with Overweight or Obesity without Type 2 Diabetes Mellitus.

Singapore, April 21 -- The Health Sciences Authority received information related to the study titled 'A Study to Evaluate the Effect of Fasting Duration and Temporary Withholding of Tirzepatide on Re... Read More


Singapore Clinical Trial: A Phase 1/2 Open-Label, Umbrella Platform Design Study of Investigational Agents in Combination With Pembrolizumab (MK-3475) With or Without Chemotherapy in Participants With 1L Locally Advanced Unresectable/Metastatic Esophageal Cancer: KEYMAKER-U06 Substudy 06E

Singapore, April 21 -- The Health Sciences Authority received information related to the study titled 'A Phase 1/2 Open-Label, Umbrella Platform Design Study of Investigational Agents in Combination W... Read More


गर्मी के चलते अस्पताल में मरीजों की लग रही लम्बी कतार

संतकबीरनगर, अप्रैल 21 -- संतकबीरनगर, हिन्दुस्तान टीम। गर्मी अपने सबाब पर है। बच्चे स्कूल जा रहे हैं और किसान खेतों में काम के लिए। महज हल्की सी लापरवाही लोगों को मरीज बना दे रही है। लू लगने के बाद लोग... Read More


AHEAD OF EARTH DAY, SENATOR MARKEY INTRODUCES PACKAGE OF LEGISLATION TO PROTECT AND MOBILIZE ALL AGES AGAINST CLIMATE CHANGE

WASHINGTON, April 21 -- Sen. Edward J. Markey issued the following press release: Senator Edward J. Markey (D-Mass.), member of the Commerce, Science, and Transportation Committee, the Environment an... Read More


'Savi Global' in Bihar's Madhubani shaping a new identity of 'made in Bihar'

Patna, April 21 -- Bihar's Madhubani, recognised worldwide for its rich cultural heritage and traditional Madhubani paintings, is now scripting a new story of industrial development and employment opp... Read More


West Asia tensions hit Nepal's tourism hard as bookings tumble

Nepal, April 21 -- Escalating tensions in West Asia are taking a visible toll on Nepal's tourism industry, with international travellers cancelling bookings in large numbers across major destinations.... Read More